What is the recommended treatment for methicillin‑sensitive Staphylococcus aureus (MSSA) peritoneal dialysis (PD) peritonitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of MSSA Peritoneal Dialysis Peritonitis

For MSSA PD peritonitis, initiate intraperitoneal cefazolin (or an anti-staphylococcal penicillin such as flucloxacillin) combined with a third-generation cephalosporin or aminoglycoside for initial empiric coverage, then narrow to cefazolin alone once MSSA is confirmed, continuing for 2-3 weeks. 1, 2

Initial Empiric Therapy

When a patient on PD presents with cloudy effluent, abdominal pain, or fever, start empiric antibiotics immediately after obtaining peritoneal fluid for culture and cell count:

  • Intraperitoneal administration is the preferred route for antibiotic delivery in PD peritonitis 3, 1
  • Empiric coverage must include both Gram-positive organisms (including MSSA/MRSA) and Gram-negative organisms (including Pseudomonas) 3, 1
  • Standard empiric regimen: vancomycin or cefazolin PLUS a third-generation cephalosporin or aminoglycoside 4, 1

Definitive Therapy Once MSSA is Confirmed

After culture results confirm methicillin-sensitive Staphylococcus aureus:

  • Narrow to cefazolin monotherapy as the preferred agent for MSSA 5, 1
  • Alternative options include flucloxacillin or other anti-staphylococcal penicillins 6, 7
  • Duration: 2-3 weeks of antibiotic therapy depending on clinical response 1, 2

Dosing Considerations

For intraperitoneal administration in PD peritonitis:

  • Cefazolin dosing should follow ISPD guideline recommendations for intermittent or continuous dosing based on the PD prescription 1
  • Monitor clinical response within 48-96 hours; effluent should clear and symptoms improve 3, 1

Special Circumstances Requiring Attention

Severe or Fulminant Presentation

If the patient presents with septic shock or unusually severe symptoms:

  • Consider Panton-Valentine leukocidin (PVL)-producing strains, which can cause fulminant peritonitis even with MSSA 6
  • In such cases, some experts add rifampicin to minimize toxin production, though this is based on limited case report data 6
  • Early catheter removal may be necessary for refractory cases 1

Monitoring for Treatment Failure

Assess for refractory peritonitis (defined as failure to improve after 5 days of appropriate antibiotics):

  • Catheter removal is recommended for refractory MSSA peritonitis 1, 2
  • Also remove catheter for relapsing peritonitis (same organism within 4 weeks of completing therapy) 1
  • Temporary hemodialysis support will be needed after catheter removal 3

Adjunctive Measures

  • Add antifungal prophylaxis (oral nystatin preferred) during antibiotic treatment to prevent secondary fungal peritonitis 3, 1
  • Treat any concurrent exit site or tunnel infections aggressively, as these increase peritonitis risk 3, 8

Common Pitfalls to Avoid

  • Do not use vancomycin for confirmed MSSA when cefazolin or anti-staphylococcal penicillins are available, as beta-lactams have superior efficacy for MSSA 5
  • Do not discontinue antibiotics prematurely even if effluent clears quickly; complete the full 2-3 week course to prevent relapse 1, 2
  • Do not delay catheter removal if peritonitis is refractory after 5 days of appropriate therapy, as prolonged conservative management increases morbidity 1

References

Research

ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2022

Research

Clinical practice guideline for the prevention and management of peritoneal dialysis associated infections in children: 2024 update.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2024

Research

Peritoneal Dialysis-Associated Peritonitis.

Clinical journal of the American Society of Nephrology : CJASN, 2019

Research

Fulminant peritonitis presumably caused by Panton-Valentine leukocidin-positive Staphylococcus aureus in a girl on peritoneal dialysis.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2013

Research

The treatment of staphylococcus peritonitis in patients on continuous ambulatory peritoneal dialysis.

Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988

Research

ISPD Catheter-related Infection Recommendations: 2023 Update.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2023

Related Questions

What is the treatment for Peritoneal Dialysis (PD) peritonitis?
When to switch from intravenous (IV) to oral (PO) antibiotics in the treatment of peritoneal dialysis catheter peritonitis?
What intraperitoneal antibiotics should be used empirically to treat peritonitis in a continuous ambulatory peritoneal dialysis (CAPD) patient?
What is the recommended treatment for peritonitis in patients on Peritoneal Dialysis (PD), following International Society for Peritoneal Dialysis (ISPD) guidelines?
What are the cellular counts in peritonitis associated with Peritoneal Dialysis (PD)?
How can I increase my high-density lipoprotein (HDL) cholesterol when low-density lipoprotein (LDL), triglycerides, and total cholesterol are already within normal limits?
Interpret the provided laboratory results—including iron studies, comprehensive metabolic panel, folate, vitamin B12, vitamin D, and thyroid function tests—and recommend any necessary treatment or dietary modifications.
What electrolyte abnormalities should be monitored and how should they be managed during a blood transfusion?
In a patient with a one‑month viral prodrome who now presents with chest pain, diffuse ST‑segment elevation on electrocardiogram and non‑obstructive coronary arteries on catheterization, is it useful to obtain a respiratory viral panel including SARS‑CoV‑2 and influenza testing?
What are the current management guidelines for a 10‑month‑old infant with fever and reduced fluid intake without signs of dehydration?
What is the appropriate next step for a patient in early pregnancy with an elevated thyroid‑stimulating hormone level of 5.95 mIU/L?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.